Additionally, pathway enrichment analysis revealed significant upregulation of certain oncogenic pathways, including PI3K/AKT, Notch, p53, and mTOR signaling pathways in PDOs.[14] These findings suggest that our PDOs possess pronounced tumor characteristics, indicating their potential to be valuable models for bladder cancer research (Figure 2G). This evidence concerns the gene AKT1 and urinary bladder cancer.